1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Development and external validation of a risk-prediction model to predict 5-year overall survival in advanced larynx cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Alpha B-crystallin - a validated prognostic factor for poor prognosis in squamous cell carcinoma of the oral cavityl
(
- Contribution to journal › Article
-
Mark
High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study.
(
- Contribution to journal › Article
- 2012
-
Mark
Using intravital microscopy to observe bevacizumab-mediated anti-angiogenesis in human head and neck squamous cell carcinoma xenografts
(
- Contribution to journal › Article
-
Mark
The increase in incidence of cancer of the tongue in the Nordic countries continues into the twenty-first century
(
- Contribution to journal › Article
- 2009
-
Mark
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
- 2008
-
Mark
Increased sensitivity to bleomycin in upper aerodigestive tract mucosa of head and neck squamous cell carcinoma patients.
(
- Contribution to journal › Article
- 2007
-
Mark
Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
(
- Contribution to journal › Article
- 2006
-
Mark
Recombinant erythropoietin beta enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical trauma.
(
- Contribution to journal › Article
-
Mark
Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays
(
- Contribution to journal › Article